Established in 1969, Parkinson Society British Columbia, governed by a voluntary Board of Directors, is supported entirely by donations from individuals, members, corporations, foundations and the dedicated efforts of volunteers.
Every person touched by Parkinson’s deserves to know that they are not alone in their journey. We are here for you. Our friendly and knowledgeable staff is committed to offering support, sharing reliable information and raising funds for programs and research.
We are part of a strong community united in our dedication to improve the lives of those affected by Parkinson’s.
Since being founded by parents in 1960, Cystic Fibrosis Canada has dramatically changed the cystic fibrosis (CF) story.
Cystic Fibrosis Canada is a national not-for-profit corporation and one of the world’s top three charitable organizations committed to improving and lengthening the lives of people living with cystic fibrosis.
In their 60 year history, they have invested more than $260M in cystic fibrosis research and care that has more than doubled life expectancy for Canadians living with cystic fibrosis. Cystic Fibrosis Canada has contributed to the global body of CF knowledge, funding research achievements such as mapping the gene that causes cystic fibrosis, in 1989. And they have advanced access to life-changing CF medicines in Canada through relentless advocacy and government relations work.
Today, Cystic Fibrosis Canada is a leading organization with a central role engaging people living with cystic fibrosis, parents and caregivers, volunteers, researchers and healthcare professionals, government and donors. They work together to change lives through treatments, research, information and support.
The Centre for Heart Lung Innovation (HLI) was established as the Pulmonary Research Laboratory in 1977 by Drs. James Hogg and Peter Pare. Since then, it has grown dramatically in scope, size and worldwide impact.
Basic and clinician scientists work together in an exciting multidisciplinary environment to address vital issues in heart, lung and critical care disease. Situated within Providence Health Care’s St. Paul’s Hospital, a University of British Columbia teaching hospital, the HLI is a translational research centre using basic molecular and cellular research discoveries to develop innovative approaches to prevent and treat human disease through complementary and connected clinical research.
The HLI focuses on developing solutions to diseases that are major causes of morbidity, mortality, and societal costs in Canada and worldwide. These include atherosclerosis and heart failure, emphysema and other chronic pulmonary diseases, severe infections, and multiple organ failure. The centre seeks out the underlying causes in order to develop strategies for prevention and treatment. Basic discoveries are linked to improved health care through clinical research and teaching, and by translating new knowledge into clinical practice at St. Paul’s Hospital and around the world.
HLI is one of several renowned research centres based at Providence Research.
We’re CLEAR, or Canadians for Leading Edge Alzheimer Research, because that’s exactly what we are. We’re on a mission to eradicate all forms of dementia, including Alzheimer disease.
A tidal wave of dementia diagnoses is on the horizon, and the best way to spare future generations the devastation of this disease is to get rid of it once and for all. And the only way to do that is through research. CLEAR is the only Canadian foundation that directs 100% of funds raised to promising scientific research into the cause, prevention, and treatment of Alzheimer Disease and other dementias.
The research we fund with Michael Smith Health Research BC could lead to the breakthrough the world has been waiting for, here in Canada or somewhere else in the world. In the global fight against this unforgiving disease, we’re all in this together.
Note: CLEAR was formerly known as the Pacific Alzheimer Research Foundation (PARF).
The major objective of the Lotte & John Hecht Memorial Foundation is the investigation and support of innovative, complementary and alternative/adjunct approaches, particularly in the treatment of cancer.
The BC Schizophrenia Society Foundation raises funds for schizophrenia research and the programs and services offered by BC Schizophrenia Society. The Society’s mission is to support families affected by schizophrenia and other serious mental illnesses in British Columbia through education, advocacy and research. The Foundation is committed to ensuring that research into schizophrenia and related disorders continues in British Columbia.
CHÉOS is a multidisciplinary health research centre founded to pursue excellence in research through the rigorous evaluation, interpretation and dissemination of health outcomes information.
Established in 1998, the Centre is jointly affiliated with the Providence Research and the University of British Columbia (UBC) Faculty of Medicine, and is located in a teaching and research hospital in the heart of Vancouver, Canada.